Christopher Krueger - Dec 2, 2022 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
Chief Business Officer
Signature
/s/ Christopher Krueger
Stock symbol
VTYX
Transactions as of
Dec 2, 2022
Transactions value $
-$1,450,730
Form type
4
Date filed
12/6/2022, 04:00 PM
Previous filing
Aug 24, 2022
Next filing
Dec 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTYX Common Stock Sale -$1.45M -50K -14.18% $29.01 303K Dec 2, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 50,000 shares sold in the price range of $29.00 to $29.21. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.